Moneycontrol PRO
you are here: HomeNewsIndia

Coronavirus pandemic | JSPL announces Rs 25 cr contribution to PM-CARES Fund

JSPL Foundation is providing food and other essential supplies to the local communities in the vicinity of its manufacturing locations.

March 31, 2020 / 12:21 PM IST
  • bselive
  • nselive
Todays L/H

Private steel maker JSPL on March 31 announced a Rs 25 crore contribution to the PM-CARES Fund to fight the outbreak of coronavirus in the country. "To support India's war against COVID-19, @JSPLCorporate is making an immediate contribution of Rs 25 crores to the PM Cares Fund. We will continue to extend every possible support to our nation in this fight against Covid-19," JSPL Chairman Naveen Jindal said in a tweet.

JSPL Foundation is providing food and other essential supplies to the local communities in the vicinity of its manufacturing locations.

As part of relief, Jindal Steel and Power Ltd (JSPL) has also upgraded its hospitals to fight this pandemic by equipping them with additional ventilators and Personal Protective Equipment (PPE) kits and creating isolation wards.

Moreover, JSPL has also engaged women Self Help Groups (SHGs) to manufacture over one lakh masks and distribute them to prevent the spread of coronavirus, Jindal said.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
The company through its philanthropic arm JSPL Foundation is distributing masks and other hygienic products such as sanitiser, hand wash and bottles of phenyl to those living near the plant sites of the company in Chhattisgarh and Odisha.
first published: Mar 31, 2020 12:15 pm
ISO 27001 - BSI Assurance Mark